Stockscreener 앱 받기
0.00
100.00%
-4.00
전일 마감가:
$4.00
열려 있는:
$0
하루 거래량:
0
Relative Volume:
0.00
시가총액:
$256.96M
수익:
-
순이익/손실:
$-71.17M
주가수익비율:
0.00
EPS:
-1.39
순현금흐름:
$-70.97M
1주 성능:
-100.00%
1개월 성능:
-100.00%
6개월 성능:
-100.00%
1년 성능:
-100.00%
1일 변동 폭
$0.00
$0.00
1주일 범위
$0.00
$0.00
52주 변동 폭
$0.00
$5.59
이노즈메 Stock (INZY) Company Profile
명칭
Inozyme Pharma Inc
전화
857-330-4340
주소
321 SUMMER STREET, BOSTON
INZY을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
INZY
Inozyme Pharma Inc
|
0.00 | 256.96M | 0 | -71.17M | -70.97M | -1.39 |
|
VRTX
Vertex Pharmaceuticals Inc
|
403.30 | 104.83B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
600.00 | 63.59B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.35 | 60.43B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
ARGX
Argen X Se Adr
|
800.00 | 48.45B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
343.87 | 37.91B | 4.56B | -176.77M | 225.30M | -1.7177 |
이노즈메 Stock (INZY) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-12 | 개시 | Raymond James | Outperform |
| 2024-09-12 | 개시 | Stifel | Buy |
| 2024-08-13 | 재개 | Jefferies | Buy |
| 2024-05-30 | 개시 | Wells Fargo | Overweight |
| 2023-03-23 | 업그레이드 | Jefferies | Hold → Buy |
| 2022-05-26 | 개시 | Jefferies | Hold |
| 2022-02-07 | 개시 | H.C. Wainwright | Buy |
| 2021-11-29 | 개시 | Needham | Buy |
| 2020-08-18 | 개시 | BofA Securities | Buy |
| 2020-08-18 | 개시 | Cowen | Outperform |
| 2020-08-18 | 개시 | Piper Sandler | Overweight |
| 2020-08-18 | 개시 | Wedbush | Outperform |
모두보기
이노즈메 주식(INZY)의 최신 뉴스
Custom watchlist performance reports with Inozyme Pharma Inc.2025 Trading Volume Trends & Daily Profit Maximizing Tips - newser.com
What Fibonacci levels say about Inozyme Pharma Inc. reboundCEO Change & Daily Stock Trend Reports - newser.com
Intraday pattern recognizer results for Inozyme Pharma Inc.Weekly Risk Report & Free Verified High Yield Trade Plans - newser.com
Inozyme Pharma Inc. stock prediction for this weekTrend Reversal & High Conviction Trade Alerts - newser.com
Real time breakdown of Inozyme Pharma Inc. stock performanceWeekly Market Summary & Momentum Based Trading Ideas - newser.com
Using data tools to time your Inozyme Pharma Inc. exit2025 Buyback Activity & Consistent Profit Focused Trading Strategies - newser.com
What drives Inozyme Pharma Inc stock priceMarket Sentiment Indicators & Join 100,000+ Investors Already Learning - earlytimes.in
Has Inozyme Pharma Inc. found a price floorQuarterly Market Summary & Risk Controlled Stock Pick Alerts - newser.com
Is Inozyme Pharma Inc a good long term investmentEarnings Season Recap & Double Digit Wealth Tips - earlytimes.in
Can Inozyme Pharma Inc. hit a new high this monthMarket Activity Recap & Precise Swing Trade Entry Alerts - newser.com
Tools to assess Inozyme Pharma Inc.’s risk profileDividend Hike & Momentum Based Trading Ideas - newser.com
Forecasting Inozyme Pharma Inc. price range with options dataPortfolio Gains Summary & Advanced Technical Analysis Signals - newser.com
Aug Momentum: What dividend growth rate does Inozyme Pharma Inc offer2025 Trading Recap & Free Community Supported Trade Ideas - خودرو بانک
Fed Watch: Is Inozyme Pharma Inc. still a buy after recent gainsWeekly Trend Report & Weekly Watchlist for Hot Stocks - خودرو بانک
Inozyme Pharma Inc. stock chart pattern explainedJuly 2025 Opening Moves & Advanced Technical Signal Analysis - newser.com
Earnings Risk: Is Inozyme Pharma Inc benefiting from innovation trendsMarket Growth Review & Low Drawdown Investment Strategies - khodrobank.com
Resistance Check: Is Inozyme Pharma Inc stock a good pick for beginnersPortfolio Profit Report & Stepwise Trade Signal Implementation - خودرو بانک
can inozyme pharma inc. hit a new high this monthQuarterly Trade Summary & Weekly Consistent Profit Watchlists - newser.com
When is the best time to exit Inozyme Pharma Inc.July 2025 Snapshot & Reliable Intraday Trade Alerts - newser.com
S P Trends: Can Inozyme Pharma Inc expand its profit marginsJuly 2025 Highlights & Safe Entry Point Identification - خودرو بانک
이노즈메 (INZY) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.68%
0.38%
자본화:
|
볼륨(24시간):